In addition, via decreasing CD13 expression, Ubenimex inhibited phosphorylation of the PI3K/AKT/mTOR pathway to downregulate P-gp and MRP1 expression, thus increasing intracellular accumulation of 5-fluorouracil and oxaliplatin in MDR GC cells. This evidence concerns the gene AKT1 and gastric cancer.